Clinical trial
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023 · The University of Texas Health Science Center, Houston, Other · Completed
Key facts
| NCT number | NCT00218023 |
|---|---|
| Title | Medications for Stopping Cocaine Dependence and Preventing Relapse |
| Official title | Screening Medications for Cocaine Cessation and Relapse Prevention |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine Abuse, Cocaine-Related Disorders |
| Intervention type | Behavioral, Drug |
| Interventions | Modafinil, Levodopa/Carbidopa, Naltrexone HCl, Placebo, Motivational Interviewing (MI), Contingency management (CM), Cognitive-Behavioral Therapy (CBT) |
| Enrollment | 101 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2012 |
| Completion | Apr 1, 2012 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: